Status:
COMPLETED
Study of HIV, HCV, APS and Phylogenetics for PWID
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Kenyatta National Hospital
Conditions:
HIV/AIDS
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will determine whether assisted partner notification services (APS) can identify and link to care, the sexual and needle-sharing partners of HIV-infected and HIV/hepatitis C (HCV) co-infect...
Detailed Description
Overview: This NIH-funded study uses assisted partner services (APS) to identify HIV-infected and HCV-infected persons who inject drugs (PWID) in Kenya and link them to care. In addition to determinin...
Eligibility Criteria
Inclusion
- \> or = 18 years of age
- Active intravenous drug use (IDU) as defined by injecting at least twice in the past month
- Willing and able to provide informed consent
- HIV infected (either new diagnosis or known diagnosis)
- Willing and able to provide locator information for sexual and/or injecting partners
Exclusion
- • Classified as at high risk for IPV\*
- \*Participants will be classified as at moderate risk for IPV if they report 1) history of IPV during their lifetime either from a current or past partner; and/or 2) fear of IPV if they participate in the study.
Key Trial Info
Start Date :
February 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2022
Estimated Enrollment :
4301 Patients enrolled
Trial Details
Trial ID
NCT03447210
Start Date
February 26 2018
End Date
February 28 2022
Last Update
November 21 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Githurai Drop-in Centre
Nairobi, Kenya
2
Ngara Health Centre
Nairobi, Kenya
3
Pangani Drop-in Centre
Nairobi, Kenya